| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |